HomePLAB 1Epidemiology & Public Health

Master Epidemiology & Public Health
for PLAB 1

Access 50+ high-yield questions tailored for the 2026 syllabus. Includes AI-powered explanations and performance tracking.

Start Free Practice View Full Syllabus
HIGH YIELD NOTES ~5 min read

Core Concepts

Epidemiology is the study of the distribution and determinants of health-related states or events in specified populations, and the application of this study to the control of health problems. Public Health aims to improve health and prevent disease through organized community efforts.

  • Measures of Disease Frequency:
    • Incidence: Number of new cases of a disease in a population over a specified period. Measures risk.
    • Prevalence: Total number of existing cases (new and old) in a population at a specific point in time or over a period. Measures burden.
    • Mortality Rate: Number of deaths from a disease in a population over a specified period.
    • Case Fatality Rate (CFR): Proportion of individuals with a disease who die from it.
    • Standardised Mortality Ratio (SMR): Compares observed deaths in a population to expected deaths (adjusting for age/sex).
  • Study Designs:
    • Descriptive: Case reports, case series, cross-sectional (snapshot of prevalence).
    • Analytical:
      • Case-Control: Retrospective, compares exposure history in cases vs. controls. Calculates Odds Ratio (OR). Good for rare diseases.
      • Cohort: Prospective or retrospective, follows exposed vs. unexposed groups over time to observe outcome. Calculates Relative Risk (RR) and Absolute Risk Reduction (ARR). Good for rare exposures.
    • Interventional:
      • Randomised Controlled Trial (RCT): Gold standard for causality, randomly assigns participants to intervention or control. Reduces confounding. Calculates NNT (Number Needed to Treat).
  • Bias: Systematic error leading to incorrect estimates.
    • Selection Bias: Differences between comparison groups (e.g., healthy worker effect).
    • Information Bias (Observation/Measurement Bias): Errors in data collection (e.g., recall bias in case-control).
    • Confounding: Third variable independently associated with both exposure and outcome, distorting the true relationship. Can be controlled for in design (randomisation, matching) or analysis (stratification, regression).
  • Causality (Bradford Hill Criteria): Strength, Consistency, Specificity, Temporality (exposure before outcome - *essential*), Biological gradient, Plausibility, Coherence, Experiment, Analogy.
  • Screening: Early detection in asymptomatic populations.
    • Sensitivity: Proportion of true positives correctly identified (TP / (TP + FN)). High sensitivity = few false negatives (good for ruling out).
    • Specificity: Proportion of true negatives correctly identified (TN / (TN + FP)). High specificity = few false positives (good for ruling in).
    • Positive Predictive Value (PPV): Probability of having the disease given a positive test (TP / (TP + FP)). Varies with prevalence.
    • Negative Predictive Value (NPV): Probability of not having the disease given a negative test (TN / (TN + FN)). Varies with prevalence.
  • Levels of Prevention:
    • Primary: Preventing disease onset (e.g., vaccination, health education).
    • Secondary: Early detection and treatment to halt progression (e.g., screening tests, early medication).
    • Tertiary: Reducing impact of established disease, improving quality of life (e.g., rehabilitation, chronic disease management).
  • Social Determinants of Health: Non-medical factors influencing health outcomes (e.g., socio-economic status, education, housing, access to healthcare).

Clinical Presentation (Application in Public Health Scenarios)

  • Outbreak Investigation: Rapid increase in cases of a disease (e.g., food poisoning, infectious disease), requiring identification of source, mode of transmission, and affected population.
  • Interpretation of Screening Results: Understanding when a positive or negative test result truly indicates disease presence or absence, especially in low vs. high prevalence settings.
  • Identifying Risk Factors: Linking patient history (lifestyle, occupation, exposures) to known epidemiological associations (e.g., smoking and lung cancer, asbestos and mesothelioma).
  • Health Inequalities: Recognising disproportionate disease burden or poorer health outcomes in specific demographic groups or geographical areas.
  • Evidence-Based Medicine: Applying findings from epidemiological studies (e.g., RCTs) to individual patient care and public health policy decisions.

Diagnosis (Gold Standard Methodologies)

In Epidemiology and Public Health, "diagnosis" refers to identifying health problems, determining their determinants, and assessing intervention effectiveness.

  • Identifying Disease Cause: Randomised Controlled Trials (RCTs) are the gold standard for establishing causal links between an intervention and an outcome.
  • Disease Surveillance: Robust, continuous data collection systems (e.g., national disease registries, mandatory reporting) are gold standard for monitoring disease trends and detecting outbreaks.
  • Evaluating Interventions: Meta-analysis and systematic reviews of high-quality RCTs provide the strongest evidence for intervention effectiveness.
  • Defining Disease Outbreaks: Clear, consistent case definitions are critical for accurate diagnosis and monitoring of outbreaks.

Management (First Line Public Health Interventions)

  • Outbreak Control:
    • Identification & Isolation: Promptly identify and isolate cases to prevent further spread.
    • Contact Tracing: Identify and monitor individuals exposed to cases.
    • Treatment & Prophylaxis: Administer appropriate medications or vaccinations.
    • Environmental Control: Address source of infection (e.g., food recall, water purification).
    • Public Health Messaging: Clear communication to inform and guide the public.
  • Disease Prevention:
    • Immunisation Programs: Widespread vaccination to achieve herd immunity.
    • Health Education & Promotion: Campaigns encouraging healthy lifestyles (e.g., anti-smoking, healthy diet, physical activity).
    • Legislation & Policy: Seatbelt laws, clean air acts, food safety regulations.
  • Screening Programs: Organised population-level screening (e.g., cervical, breast, bowel cancer screening) for early detection.
  • Addressing Health Inequalities: Targeted interventions and policies for vulnerable populations.

Exam Red Flags

  • Incidence vs. Prevalence: Frequently confused. Remember Incidence = NEW cases (risk), Prevalence = ALL cases (burden).
  • Sensitivity/Specificity vs. PPV/NPV: Sensitivity/Specificity are properties of the test itself. PPV/NPV are dependent on disease prevalence in the tested population. A highly sensitive/specific test may have a low PPV in a low prevalence population.
  • Common Biases: Be able to identify and differentiate selection bias, information bias (e.g., recall bias), and confounding. Understand how randomisation helps control confounding.
  • Temporality: Crucial for causality – exposure must precede outcome. Other Bradford Hill criteria strengthen but do not prove causality.
  • Study Strengths/Weaknesses: Know the main advantages and disadvantages of Case-Control (good for rare diseases, prone to recall bias) vs. Cohort (good for rare exposures, expensive, long duration) vs. RCT (gold standard for efficacy, ethical limitations).
  • NNT/NNH: Number Needed to Treat (beneficial) or Harm (adverse effect) are absolute measures derived from RCTs and are high-yield for interpretation.

Sample Practice Questions

Question 1

A new screening test for Type 2 Diabetes is introduced in a primary care setting. In a population of 1000 individuals, 100 truly have diabetes. The test correctly identifies 90 of those with diabetes (true positives) and incorrectly identifies 50 individuals without diabetes as having the condition (false positives). If a patient tests positive for diabetes with this new screening test, what is the probability that they actually have diabetes?

A) Sensitivity
B) Specificity
C) Positive Predictive Value (PPV)
D) Negative Predictive Value (NPV)
Explanation: This area is hidden for preview users.
Question 2

A 60-year-old patient with well-controlled hypertension and type 2 diabetes is enrolled in a hospital program that provides regular foot care clinics, education on diabetic foot self-management, and immediate access to podiatry services to prevent the development of diabetic foot ulcers. What level of prevention is this program primarily aiming for regarding diabetic foot ulcers?

A) Primary prevention
B) Secondary prevention
C) Tertiary prevention
D) Quaternary prevention
Explanation: This area is hidden for preview users.
Question 3

A national health agency is considering implementing a new universal screening program for a relatively rare genetic condition in newborns. The condition, if detected early, can be managed with dietary changes to prevent severe intellectual disability. However, the diagnostic test has a small risk of false positives leading to parental anxiety and unnecessary follow-up tests.

A) The condition must be common in the population to justify screening.
B) There must be an effective treatment available for the condition once symptoms become apparent.
C) The screening test must be perfectly sensitive and specific to avoid any false results.
D) The overall benefits of early detection and treatment must outweigh the potential harms of the screening process.
Explanation: This area is hidden for preview users.

Ready to see the answers?

Unlock All Answers

PLAB 1

  • ✓ 50+ Epidemiology & Public Health Questions
  • ✓ AI Tutor Assistance
  • ✓ Detailed Explanations
  • ✓ Performance Analytics
Get Full Access